Neobiosys
NeoBioSys, founded in 2009 and based in Issoire, specializes in customized solutions in industrial microbiology, focusing on process acceleration, bioprocess development, and intensification. The company serves various sectors including health, agro-food, environment, and civil engineering, with a commitment to innovative biotechnological solutions and sustainable development. It operates multiple specialized sites, including ISO 22000 and FSSC 22000 certified facilities, and offers services from research to production, including fermentation, vaccine development, and probiotic projects. NeoBioSys also develops internal research programs and produces fermented animal feeds, aiming to leverage microorganisms for health, production, and environmental solutions.
Industries
Nr. of Employees
small (1-50)
Neobiosys
Products
Contract-produced fermented complementary feed (animal)
Fermented complementary feed products manufactured under contract for livestock and aquaculture applications, available in freeze-dried, frozen concentrate or liquid formats.
Clinical-trial microbial product manufacturing (service offering)
Production and packaging of clinical and preclinical batches of live microbial therapeutics, including USP/DSP development and process transfer for trial supply.
Contract-produced fermented complementary feed (animal)
Fermented complementary feed products manufactured under contract for livestock and aquaculture applications, available in freeze-dried, frozen concentrate or liquid formats.
Clinical-trial microbial product manufacturing (service offering)
Production and packaging of clinical and preclinical batches of live microbial therapeutics, including USP/DSP development and process transfer for trial supply.
Services
Services to intensify and improve microbial bioprocesses including cycle time reduction, productivity improvement and integration of real-time monitoring.
End-to-end development from strain screening, USP/DSP development to pilot and industrial production under certified quality systems.
Contract production and packaging of fermented complementary feeds for livestock and aquaculture, delivered in multiple formats.
Development of upstream and downstream processes and production of clinical or preclinical batches for microbiome-based therapeutics and trial supplies.
Deployment of online analytical tools and PAT workflows to monitor critical process parameters and enable improved process control.
Services to intensify and improve microbial bioprocesses including cycle time reduction, productivity improvement and integration of real-time monitoring.
End-to-end development from strain screening, USP/DSP development to pilot and industrial production under certified quality systems.
Contract production and packaging of fermented complementary feeds for livestock and aquaculture, delivered in multiple formats.
Development of upstream and downstream processes and production of clinical or preclinical batches for microbiome-based therapeutics and trial supplies.
Deployment of online analytical tools and PAT workflows to monitor critical process parameters and enable improved process control.
Expertise Areas
- Bioprocess development and intensification
- Industrial fermentation and scale-up
- Food and feed production (fermented products)
- Microbiota and microbiome-related projects
Key Technologies
- Bioreactors (up to 5000 L)
- Fermentation process engineering
- Lyophilization (freeze-drying)
- Process Analytical Technology (PAT) and online gas analysis
News & Updates
NeoBioSys contributed to a project awarded EUR 3.8 million by the European Innovation Council to develop a bacteria-based therapy for gout.
NeoBioSys team wishes a happy new year to its community.
The company has joined the GIMRA initiative to advance microbiome research.
The Défi’Flor® product received the Trophies of Innovation Clermont Auvergne 2018 in the 'Science & Research' category.
NeoBioSys contributed to a project awarded EUR 3.8 million by the European Innovation Council to develop a bacteria-based therapy for gout.
NeoBioSys team wishes a happy new year to its community.
The company has joined the GIMRA initiative to advance microbiome research.
The Défi’Flor® product received the Trophies of Innovation Clermont Auvergne 2018 in the 'Science & Research' category.